industry sentiment
Enough evidence
Current company news
Industry news sentiment
Biotechnology news sentiment
This is a global view using qualified companies from every covered country.
Current reading
Company news is mixed
Positive and negative company readings are balancing each other. The company list below shows where they differ.
What supports this score
100% of the stories are tied directly to a company.
What limits this score
Negative company breadth is 36/100.
Confidence is 49/100, so this group score should be treated cautiously.
Only 28% of measured companies had a positive one-week price move.
Same-company comparison · 7 days
Where the news is changing
The same companies, scored using the same methodology at both dates. A move of at least 3 points identifies a shift. New coverage and methodology changes are excluded. Cross-listings appear once, using the best-supported comparable listing.
Median score change—
- Improving
- 0
- Little change
- 0
- Weakening
- 0
Strengthening tone
No qualifying upward shifts in the matched sample.
Weakening tone
No qualifying downward shifts in the matched sample.
Company breadth
How widely the direction is shared
Constructive527.8%
Balanced316.7%
Cautious1055.6%
Each qualified listing has one vote here. The headline score also weighs evidence quality and adjusts for matched company listings.
Score distribution
How company scores are spread
3Strong caution
7Cautious
3Balanced
5Constructive
0Strongly constructive
The balanced band covers scores from 43 to 57. A cluster near 50 can reflect mixed news; the confidence grid shows how much support sits behind it.
Evidence quality
Direction meets confidence
| News tone | Developing35–49 | Usable50–69 | High70–100 |
|---|---|---|---|
| Constructive | 527.8% | 00.0% | 00.0% |
| Balanced | 316.7% | 00.0% | 00.0% |
| Cautious | 316.7% | 738.9% | 00.0% |
0 directional readings have high confidence. Shading shows the number of readings, not the strength of sentiment.
Group confidence and source totals
49/100 group confidence
High confidence0
Usable evidence7
Developing11
759 company-news stories and 227 company–publisher observations (publishers may recur across companies). 100% is tied directly to a company.
13-week history
News score and company breadth
06 Jul17 Aug28 Sep
News scoreCompany breadthNeutral 50
Weekly means for the current set of 18 qualified listings. Each point uses only measured readings under the current company methodology; sample size can vary. Gaps remain visible. Later headlines do not rewrite stored history.
View weekly scores and sample sizes
| Week | News score | Breadth | Readings |
|---|---|---|---|
| 6 Jul 2026 | — | — | 0 |
| 13 Jul 2026 | — | — | 0 |
| 20 Jul 2026 | — | — | 0 |
| 27 Jul 2026 | — | — | 0 |
| 3 Aug 2026 | — | — | 0 |
| 10 Aug 2026 | — | — | 0 |
| 17 Aug 2026 | — | — | 0 |
| 24 Aug 2026 | — | — | 0 |
| 31 Aug 2026 | — | — | 0 |
| 7 Sep 2026 | — | — | 0 |
| 14 Sep 2026 | — | — | 0 |
| 21 Sep 2026 | 48.0 | 50.0 | 4 |
| 28 Sep 2026 | 45.8 | 36.7 | 15 |
Price check
How news tone compares with price
Price is shown beside the news score. It never changes the news score.
Group breakdown
Countries in this industry
Highest scores
🇺🇸 United States46.018 companies · 49/100 confidenceLowest scores
🇺🇸 United States46.018 companies · 49/100 confidenceFurther breakdown
Sectors containing this industry
Highest scores
Healthcare46.018 companies · 49/100 confidenceLowest scores
Healthcare46.018 companies · 49/100 confidenceGroup comparison
How this group compares
Specialty Business Services67.151/100 confidence · 4 equitiesStaffing & Employment Services64.037/100 confidence · 1 equitiesElectronics & Computer Distribution60.050/100 confidence · 1 equitiesReal Estate Services59.037/100 confidence · 1 equitiesSteel46.543/100 confidence · 3 equitiesMedical Devices46.248/100 confidence · 9 equitiesBiotechnology46.049/100 confidence · 18 equitiesFootwear & Accessories44.840/100 confidence · 2 equitiesApparel Manufacturing44.437/100 confidence · 2 equitiesHealth Information Services34.848/100 confidence · 2 equitiesEducation & Training Services34.055/100 confidence · 1 equitiesPublishing33.058/100 confidence · 1 equitiesUtilities - Renewable32.046/100 confidence · 1 equities
News subjects
Most common subjects
Market update1055.6% of companies · score 52.9
Regulatory and legal844.4% of companies · score 37.3
Publishers
Where the latest stories came from
The National Law Review211.1% of companies · score 35.5
ACCESS Newswire211.1% of companies · score 36.0
finance.yahoo.com211.1% of companies · score 59.8
simplywall.st211.1% of companies · score 59.4
Carroll County Mirror-Democrat15.6% of companies · score 31.0
Pluang15.6% of companies · score 32.0
webull.com15.6% of companies · score 32.0
The Globe and Mail15.6% of companies · score 35.0
Summary
Coverage and score spread
Score rank#85among 103 measured industries
Parent spread-4.2versus Healthcare
Score spread11.7higher values mean companies differ more
Companies
The companies used in this score
Constructive leaders
VRTX64
Vertex Pharmaceuticals Inc
News confirmed by price · +3.5% 1W
Market update · 47/100 confidence · 76 direct storiesSRRK60
Scholar Rock Holding Corp
News confirmed by price · +4.2% 1W
Market update · 37/100 confidence · 40 direct storiesMESO59
Mesoblast Ltd
Balanced read · -0.1% 1W
Regulatory and legal · 43/100 confidence · 12 direct storiesAXSM59
Axsome Therapeutics Inc
Positive news being faded · -6.1% 1W
Market update · 40/100 confidence · 55 direct storiesMRNA58
Moderna Inc
News confirmed by price · +29.1% 1W
Market update · 36/100 confidence · 113 direct storiesRARE56
Ultragenyx
Balanced read · -0.1% 1W
Market update · 47/100 confidence · 56 direct storiesINCY55
Incyte Corporation
Balanced read · -1.1% 1W
Market update · 36/100 confidence · 56 direct storiesVKTX54
Viking Therapeutics Inc
Price moving ahead of tone · +22.7% 1W
Market update · 38/100 confidence · 70 direct storiesCautious laggards
AARD31
Aardvark Therapeutics, Inc. Common Stock
Caution confirmed by price · -5.9% 1W
Regulatory and legal · 62/100 confidence · 29 direct storiesARDX32
Ardelyx Inc
Balanced read · +0.0% 1W
Regulatory and legal · 63/100 confidence · 21 direct storiesGUTS32
Fractyl Health, Inc. Common Stock
Caution confirmed by price · -19.1% 1W
Regulatory and legal · 61/100 confidence · 28 direct storiesUNCY35
Unicycive Therapeutics Inc
Caution confirmed by price · -2.2% 1W
Regulatory and legal · 58/100 confidence · 20 direct storiesSPRY35
ARS Pharmaceuticals, Inc
Balanced read · -0.7% 1W
Regulatory and legal · 50/100 confidence · 14 direct storiesCAPR36
Capricor Therapeutics Inc
Caution confirmed by price · -7.7% 1W
Regulatory and legal · 51/100 confidence · 31 direct storiesREPL36
Replimune Group Inc
Caution confirmed by price · -5.4% 1W
Regulatory and legal · 50/100 confidence · 19 direct storiesCLLS36
Cellectis SA
Caution confirmed by price · -3.9% 1W
Market update · 42/100 confidence · 28 direct storiesMost evidence
MRNA58
Moderna Inc
News confirmed by price · +29.1% 1W
Market update · 36/100 confidence · 113 direct storiesVRTX64
Vertex Pharmaceuticals Inc
News confirmed by price · +3.5% 1W
Market update · 47/100 confidence · 76 direct storiesVKTX54
Viking Therapeutics Inc
Price moving ahead of tone · +22.7% 1W
Market update · 38/100 confidence · 70 direct storiesREGN42
Regeneron Pharmaceuticals Inc
Balanced read · +0.4% 1W
Market update · 43/100 confidence · 59 direct storiesRARE56
Ultragenyx
Balanced read · -0.1% 1W
Market update · 47/100 confidence · 56 direct storiesINCY55
Incyte Corporation
Balanced read · -1.1% 1W
Market update · 36/100 confidence · 56 direct storiesAXSM59
Axsome Therapeutics Inc
Positive news being faded · -6.1% 1W
Market update · 40/100 confidence · 55 direct storiesSRRK60
Scholar Rock Holding Corp
News confirmed by price · +4.2% 1W
Market update · 37/100 confidence · 40 direct storiesLatest company readings
Recent company news scores
VRTX64
Could Vertex Pharmaceuticals (VRTX)’s Kidney Breakthrough Unlock a New Opportunity for Maze Therapeutics (MAZE)?
finance.yahoo.com · Market update · News confirmed by price
47/100 confidence · 95% direct evidenceINCY55
Mirum Pharmaceuticals and Incyte Compete Regeneron with Abnormal Bone Formation Treatment
finance.yahoo.com · Market update · Balanced read
36/100 confidence · 89% direct evidenceMESO59
Has Mesoblast (ASX:MSB) cleared a key FDA manufacturing hurdle?
Kalkine Media · Regulatory and legal · Balanced read
43/100 confidence · 96% direct evidenceAXSM59
Is Axsome Therapeutics (AXSM) Undervalued As Caregiver Survey Data Tests Its CNS Growth Story?
simplywall.st · Market update · Positive news being faded
40/100 confidence · 98% direct evidenceREPL36
Lost Money on Replimune Group, Inc. (REPL)? Urged to Join Class Action Before October 5, 2026 – Contact Levi & Korsinsky
ACCESS Newswire · Regulatory and legal · Caution confirmed by price
50/100 confidence · 100% direct evidenceVKTX54
Viking Therapeutics (VKTX) Delivers Great VK2735 Results: Here's a Word of Caution
Motley Fool · Market update · Price moving ahead of tone
38/100 confidence · 92% direct evidenceMRNA58
Moderna (MRNA) Surges 29% Amid Healthcare Sector Gains on Septem
GuruFocus · Market update · News confirmed by price
36/100 confidence · 87% direct evidenceACAD39
Acadia Pharmaceuticals (ACAD) Stock Trades At A Discount After A 29% Drop
Simply Wall St. · Market update · Caution confirmed by price
46/100 confidence · 95% direct evidenceRARE56
Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) Stock Has Consensus Price Target of $34.58 According to Analysts
MarketBeat · Market update · Balanced read
47/100 confidence · 95% direct evidenceSRRK60
FDA Approval Might Shift The Case For Scholar Rock Stock (SRRK)
simplywall.st · Market update · News confirmed by price
37/100 confidence · 98% direct evidenceCLLS36
Bronstein, Gewirtz & Grossman, LLC Encourages Cellectis S.A. (CLLS) Stockholders to Inquire about Securities Investigation
The National Law Review · Market update · Caution confirmed by price
42/100 confidence · 100% direct evidenceAARD31
Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Carroll County Mirror-Democrat · Regulatory and legal · Caution confirmed by price
62/100 confidence · 100% direct evidenceARDX32
Uncovering Potential: Penny Stocks To Watch In September 2026
webull.com · Regulatory and legal · Balanced read
63/100 confidence · 100% direct evidenceSPRY35
Kaplan Fox Encourages Investors of ARS Pharmaceuticals Inc. (NASDAQ: SPRY) to Contact the Firm Before Lead Plaintiff Deadline on October 5, 2026
The National Law Review · Regulatory and legal · Balanced read
50/100 confidence · 100% direct evidenceCAPR36
Investors in Capricor Therapeutics, Inc. (CAPR): Protect Your Rights - Contact Levi & Korsinsky Before September 28, 2026
ACCESS Newswire · Regulatory and legal · Caution confirmed by price
51/100 confidence · 100% direct evidenceUNCY35
Kaplan Fox Encourages Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Investors to Contact the Firm Before the Deadline on November 2, 2026
The Globe and Mail · Regulatory and legal · Caution confirmed by price
58/100 confidence · 100% direct evidenceGUTS32
Fractyl Health faces lawsuit over alleged false claims about therapy effectiveness.
Pluang · Regulatory and legal · Caution confirmed by price
61/100 confidence · 100% direct evidenceREGN42
Regeneron to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on October 30, 2026
GlobeNewswire · Market update · Balanced read
43/100 confidence · 100% direct evidenceHow it works
How to read this page
The score measures positive and negative company news after relevance, publisher quality, subject importance and freshness weighting. 50 is neutral. Matched cross-listings share one company weight; coverage and breadth counts describe listings.
Breadth shows how many companies share the same direction. A few extreme scores cannot make breadth look strong.
Confidence uses the amount of news, direct company matches, publisher variety, freshness and agreement. It is separate from direction.
Completed weekly prices show whether prices moved with or against the news. Price never changes the news score.
Company readings that do not pass the checks are excluded. A subgroup needs at least five companies before it is ranked.
This page describes current published news. It is not a forecast, price target or recommendation.